A hospital monitor flatlines, a doctor says the words, and in the version of events you’ve always accepted, that’s the end of the story. But somewhere in Scottsdale, Arizona, an organisation has spent fifty years operating on a different assumption: that the seconds after “time of death” are not a full stop but a deadline — and that what happens in the next few hours decides whether a person is gone or merely paused. Whether they’re right is one of the most genuinely uncertain bets a human can make.
The short version: Alcor is a non-profit cryonics provider, operating since 1972, that preserves legally deceased members in liquid nitrogen on the speculative bet that future medicine could repair and revive them. Neuro-preservation (brain only) runs roughly $200,000–$250,000 and whole-body $500,000+, funded through life insurance. Its distinctive strengths are aligned incentives (staff are members too), published case reports, and decades of legal standing — but revival has never been achieved and may never be possible, so this is a long-odds wager, not a proven service.
What Alcor is, and why “death as a pause” is its founding bet
You’ve been told death is final. Alcor’s premise is that legal death (heart stoppage) happens well before biological death (irreversible destruction of the brain’s structure), and that the gap between them is a rescue interval.
The 12-point setup for a private, secure, high-output digital life — in one afternoon. No spam, unsubscribe anytime.
The reasoning runs like this: if your connectome — the pattern of neural connections that encodes your mind — survives intact, then some future technology (molecular repair, high-resolution scanning, or emulation) might theoretically restore you. Alcor has operated on that assumption since 1972, using vitrification chemistry developed in part by 21st Century Medicine to replace blood with cryoprotectant compounds that aim to prevent ice-crystal damage at −196°C.
Here’s the reframe that organises everything Alcor does: a cremated or buried brain has a structurally guaranteed zero chance of any future; a preserved one has an unknown, unproven, non-zero one. That is the entire bet, and it’s important to state its honesty plainly — Alcor has 200+ patients in suspension and publishes technical case reports including failures, but not a single revival. The transparency is real; the success rate is, so far, undemonstrated.
How Alcor actually works: the Standby, Stabilization, Transport stack
The whole operation lives or dies on speed — once the heart stops, hypoxic brain damage becomes a clock. Alcor’s workflow:
- Medical standby team: you register and carry a membership alert card; if you’re dying or hospitalised, you notify Alcor and they deploy a team, coordinating with local funeral directors and medical staff.
- Immediate stabilisation: the team begins cardiopulmonary support and cools the body rapidly using ice and cold saline, slowing cellular metabolism to buy time before vitrification.
- Transport to Scottsdale, AZ: the patient travels to Alcor’s facility under continuous care.
- Vitrification protocol: over four to six hours, blood is gradually replaced with M22 cryoprotectant, intended to prevent the ice-crystal formation that would destroy cell structures.
- Long-term storage: the body (whole-body) or brain (neuro) is cooled to −196°C in a liquid-nitrogen dewar. Temperature is monitored continuously, and because the dewars are gravity-fed, even a total power failure keeps patients cold for weeks.
Neuro vs whole-body: why brain-only is Alcor’s signature
Alcor offers two preservation options, and the price gap is steep:
- Neuro-preservation (~$200k–$250k): brain and upper cervical spine only. The case for it: smaller volume means more uniform vitrification, more aggressive cooling, and lower storage cost — on the assumption that future technology could grow or synthesise a new body from the preserved connectome.
- Whole-body preservation (~$500k+): the entire body, preserving peripheral organs and nervous system, as a hedge in case whole-body regeneration turns out to be the more tractable path.
Neuro is Alcor’s signature because, in its framing, identity lives in synaptic patterns rather than the skeleton. Whether that framing is correct is, again, an open question riding on a future no one can verify — so treat the neuro/whole-body choice as a bet within a bet.
The economic durability problem: why Alcor is built to outlive itself
The sharpest fear: what if Alcor goes bankrupt? The body thaws, the brain degrades, the preservation is wasted.
Alcor’s answer is the Patient Care Trust — a legally separate endowment holding $20M+ in conservative assets (bonds, real estate, stocks), dedicated solely to long-term patient maintenance. It’s structured so that even if Alcor the operating organisation fails, the Trust keeps paying for dewar maintenance, nitrogen, and monitoring, and it can’t be seized to cover Alcor’s operating debts. In 54 years of operation, Alcor reports no financial crisis that risk signalened patient safety.
The honest caveat: this structure is genuinely robust by the standards of any organisation — but the bet requires institutional survival across a century or more, a timescale on which no track record can offer real assurance. The Trust lowers the risk; it cannot remove it.
The aligned-incentive logic: staff are also patients
Here’s the genuinely unusual part: Alcor’s leadership and staff hold their own preservation contracts. The people managing your suspension intend to be in the same vault someday.
This is extreme skin-in-the-game alignment — you’re not a customer being sold a service so much as a logistical peer in a shared, uncertain mission. It’s the most reassuring structural feature Alcor has: the operators carry the same downside you do. It doesn’t make revival more likely, but it does make neglect far less likely, and on a multi-decade preservation that distinction matters.
The revival challenge: how would an Alcor patient actually come back?
This is the hard, honest core: revival is speculative, and current science has no working roadmap. The plausible theories on offer:
- Whole-Brain Emulation (WBE): high-resolution scanning of the preserved connectome, mapped onto a computer or synthetic neural substrate, so the “mind” runs digitally or in a synthetic body.
- Molecular repair: nanotechnology or advanced biotech repairs vitrification damage and restores the brain to working condition.
- Hybrid revival: partial biological restoration plus partial digital emulation, depending on what’s possible.
None of these exists. Alcor’s position is that preserving the connectome now maximises future options — a degraded brain has zero paths, a preserved one has several speculative ones. That’s a defensible philosophical stance, but it is a stance, not a demonstrated outcome, and no honest reading should blur the two.
How to join Alcor: membership and funding mechanics
- Apply for membership at Alcor.org, answering health questions; most applications are reviewed within 2–4 weeks. Membership dues are modest (free or ~$100/year) — the real cost is the preservation contract.
- Fund your preservation via life insurance. Rather than paying $200k upfront, you take a term or whole-life policy naming Alcor as beneficiary; the payout covers preservation on legal death. A healthy 40-year-old might pay $40–$80/month for a $250k policy; a 60-year-old, $150–$300/month.
- Execute standby instructions. Update your will and medical directives, carry the Alcor alert card, and notify Alcor immediately if hospitalised with a terminal condition so they can coordinate cooling and transport at the moment of legal death.
- Inform your family. This is critical — your family will experience your legal death as final unless you’ve prepared them, and their cooperation during the standby window is essential. Alcor provides family resources.
The regulatory and legal foundation
Alcor is a US non-profit registered in Arizona, and it operates legally because post-mortem cryopreservation isn’t illegal — once you’re declared legally dead, disposition of your body is your choice, like burial or cremation. Alcor holds licences to operate as a scientific-research facility under Arizona law, and members sign informed-consent documents explicitly acknowledging that revival is speculative and uncertain. That it has survived legal scrutiny for 50+ years is a meaningful sign it isn’t operating in a grey zone.
The transparency audit: what Alcor publishes, and why it matters
Alcor publishes detailed case reports — medical histories, time from cardiac arrest to cooling, vitrification outcomes, and storage data — including failures. Most life-extension organisations would bury their failures; exposing them to drive improvement is an unusually strong signal of good faith. Radical transparency about your limitations is the closest thing this field has to credibility — though it’s worth being clear that publishing honest failure reports demonstrates integrity, not that the underlying revival bet will pay off.
Frequently asked questions
Is vitrification damage reversible?
Not with current technology. Alcor’s argument is that future molecular-repair technology could rebuild the preserved structures from the brain’s 3D map. Whether that technology ever exists is unknown — this is the central unproven assumption, and no one can honestly promise it.
What if the power grid fails and the liquid nitrogen runs out?
Alcor’s dewars are gravity-fed, so liquid nitrogen flows without active pumps; patients stay frozen for weeks even in a total electrical failure, and backup nitrogen is held offsite. Only multiple simultaneous catastrophic failures would cause thawing.
Is Alcor a cult?
The evidence doesn’t support the label: members lead diverse independent lives, there’s no charismatic leader demanding devotion, membership is contractual rather than religious, and the organisation is transparent about its science and limits. It’s a speculative bet on technology, not a faith movement — though, like any specialised community, members do form bonds around shared interest.
What’s the actual probability revival works?
No one can honestly quantify it, and Alcor doesn’t try to. It depends on unknowns — whether emulation is possible, whether molecular repair can work at scale, whether a future civilisation has the resources and interest. Any figure you’ve seen is a guess. The only defensible statement is “non-zero but unproven,” which beats burial’s structural zero by an unknown margin.
Can I change my mind after joining?
Yes. Cryopreservation is voluntary; before legal death you can withdraw at any time and cancel the policy. Once in suspension you can’t withdraw (you’re legally dead), though family could theoretically request thawing — which Alcor would try to dissuade based on your prior wishes.
The verdict: is Alcor right for you?
Consider Alcor if: you view death as a problem worth probing rather than an unquestioned ending; you can afford the life-insurance premiums without strain; you’re genuinely comfortable with speculative, unproven science; and you find Alcor’s track record, Trust structure, and transparency reassuring.
Skip Alcor if: you’ve made peace with biological finitude, or believe revival is impossible or unethical; the premiums would strain your finances; you’d rather pour every dollar into the life you’re certain you have; or you simply don’t want to bet on a future you can’t see.
The honest final logic: Alcor isn’t a guarantee of anything, and it would be wrong to call it a “mandatory” anything — it’s an unproven, long-odds insurance against permanent deletion, chosen by people for whom a small unknown chance is worth a modest premium. A preserved brain has speculative futures; a cremated one has none. For someone who has looked clearly at the uncertainty and still finds the wager worth making, it’s a coherent choice — and for someone who hasn’t, walking away with open eyes is an equally sovereign one. The value isn’t certainty. It’s deciding the biggest question yourself, instead of letting the default decide for you.
Related reading: Proton Drive Review: the logic of encrypted persistence and the data sovereignty unhack.
Join the Inner Circle
Weekly dispatches. No algorithms. No surveillance. Just sovereign intelligence.